As previously disclosed, the studies did not meet pre-specified co-primary, secondary, or exploratory biomarker endpoints The ...

Cassava Sciences is laying off 10 employees—a third of its workforce—as the biotech seeks to conserve cash in the wake of the phase 3 fail of its lead Alzheimer’s disease drug. The RETHINK-ALZ trial ...

You may have noticed more products being sold that contain cassava, a starchy vegetable used in many parts of the world. But a new investigation found some products contain concerning levels of lead.

In our series of letters from African journalists, Ghanaian Elizabeth Ohene considers the call of Uganda's President Yoweri Museveni for people to eat the humble cassava as the price of wheat soars ...

Cassava Sciences is imploding — and as it crumbles, a dark, ugly corner of the Alzheimer’s disease world is being exposed and will hopefully get cleaned up. Remi Barbier, Cassava’s longtime CEO, has ...

The biotech is paying $40 million not to acquire a drug or fund a development program, but to satisfy a regulator. The money is going toward a settlement with the Securities and Exchange Commission.

The three staple crops dominating modern diets – corn, rice and wheat – are familiar to Americans. However, fourth place is held by a dark horse: cassava. Over the course of millennia, Indigenous ...

A joint study by researchers at the Koforidua Technical University and the Kwame Nkrumah University of Science and Technology (KNUST) has uncovered disturbing levels of cyanide and lead in cassava ...

Cassava Sciences disclosed Monday that it's being investigated by government agencies. The biotech is testing a treatment for Alzheimer's disease that is being scrutinized by scientists. The Wall ...